Study summary
Larvicides (CDC Mosquito Control guidance)
U.S. Centers for Disease Control and Prevention
Read the original paper- Study type
- Review
- Year
- 2024
- Published in
- CDC Division of Vector-Borne Diseases
- Evidence strength
- Well-supported evidence
Summary
CDC public-health guidance on larvicides.
Key findings
CDC states Bti and B. sphaericus selectively kill mosquito larvae with negligible effect on non-target organisms and are favored for public-health larviciding; methoprene is a low-risk larvicide with very low mammalian toxicity and non-persistence.
Limitations
Summary guidance rather than primary data.